Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Timing and Consequences on Behavior01:08

Timing and Consequences on Behavior

368
In operant conditioning, the timing of reinforcement is crucial. For animals like rats and cats, immediate reinforcement (within a few seconds) is much more effective than delayed reinforcement. For example, a food reward for a rat needs to follow within 30 seconds of pressing a bar to be effective. 
Humans, however, can respond to delayed reinforcers. We often make decisions between immediate small rewards and delayed larger rewards. This ability to delay gratification is a significant...
368
Chromatin Position Affects Gene Expression02:35

Chromatin Position Affects Gene Expression

24.7K
Chromatin is the massive complex of DNA and proteins packaged inside the nucleus. The complexity of chromatin folding and how it is packaged inside the nucleus greatly influences  access to genetic information. Generally, the nucleus' periphery is considered transcriptionally repressive, while the cell's interior is considered a transcriptionally active area. 
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
24.7K
What is Gene Expression?01:42

What is Gene Expression?

195.1K
Overview
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...
195.1K
What is Gene Expression?01:36

What is Gene Expression?

11.1K
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is comprised  of nucleotides and proteins are comprised of amino acids, a mediator is required to convert the information encoded in DNA into proteins. This mediator is the messenger RNA (mRNA). mRNA copies the blueprint from DNA by a process called transcription. In eukaryotes, transcription occurs in the nucleus by complementary base-pairing with the DNA template. The mRNA is then...
11.1K
Expressing Solution Concentration02:48

Expressing Solution Concentration

66.1K
A solute is a component of a solution that is typically present at a much lower concentration than the solvent. Solute concentrations are often described with qualitative terms such as dilute (of relatively low concentration) and concentrated (of relatively high concentration).
Concentrations may be quantitatively assessed using a wide variety of measurement units, each convenient for particular applications. Molarity (M) is a useful concentration unit for many applications in chemistry.
66.1K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

16.3K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Restoration of the immune system with base editing and non-genotoxic conditioning in a Rag2 point-mutant mouse model.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Experience of bortezomib use in refractory autoimmune neurological disorders.

Multiple sclerosis and related disorders·2025
Same author

CaP Nanoparticles Improve the Effect of dsRNA on Gene Expression, Growth, and Mycotoxin Production of Toxigenic <i>Fusarium graminearum</i>.

International journal of molecular sciences·2025
Same author

GFP-on mouse model for interrogation of in vivo gene editing.

Nature communications·2025
Same author

Highly efficient <i>in vivo</i> hematopoietic stem cell transduction using an optimized self-complementary adeno-associated virus.

Molecular therapy. Methods & clinical development·2025
Same author

Calcium Phosphate Nanoparticles as Carriers of Low and High Molecular Weight Compounds.

International journal of molecular sciences·2024

Related Experiment Video

Updated: Jan 23, 2026

Using Zebrafish Larvae to Study the Pathological Consequences of Hemorrhagic Stroke
06:36

Using Zebrafish Larvae to Study the Pathological Consequences of Hemorrhagic Stroke

Published on: June 5, 2019

8.8K

DUX4 Pathological Expression: Causes and Consequences in Cancer.

Carla Dib1, Vlada Zakharova2, Ekaterina Popova3

  • 1UMR 8126, CNRS, Univ. Paris-Sud, Université Paris Saclay, Institut Gustave Roussy, F-94805 Villejuif, France; LIA 1066 LFR2O French-Russian Joint Cancer Research Laboratory, 94805 Villejuif, France.

Trends in Cancer
|June 9, 2019
PubMed
Summary

The double homeobox DUX4 gene, studied in facioscapulohumeral dystrophy (FSHD), is now linked to cancers. Therapies for FSHD may offer new treatment options for these malignancies.

Keywords:
DUX4FSHDleukaemiasarcoma

More Related Videos

3D Cell-Printed Hypoxic Cancer-on-a-Chip for Recapitulating Pathologic Progression of Solid Cancer
10:51

3D Cell-Printed Hypoxic Cancer-on-a-Chip for Recapitulating Pathologic Progression of Solid Cancer

Published on: January 5, 2021

5.1K
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.2K

Related Experiment Videos

Last Updated: Jan 23, 2026

Using Zebrafish Larvae to Study the Pathological Consequences of Hemorrhagic Stroke
06:36

Using Zebrafish Larvae to Study the Pathological Consequences of Hemorrhagic Stroke

Published on: June 5, 2019

8.8K
3D Cell-Printed Hypoxic Cancer-on-a-Chip for Recapitulating Pathologic Progression of Solid Cancer
10:51

3D Cell-Printed Hypoxic Cancer-on-a-Chip for Recapitulating Pathologic Progression of Solid Cancer

Published on: January 5, 2021

5.1K
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.2K

Area of Science:

  • Genetics and Molecular Biology
  • Oncology
  • Rare Diseases

Background:

  • The double homeobox 4 (DUX4) gene is primarily recognized for its role in facioscapulohumeral dystrophy (FSHD), a genetic muscle disorder.
  • FSHD is characterized by a specific deletion on chromosome 4q, leading to aberrant DUX4 expression.
  • Emerging research indicates a connection between DUX4 and the development of certain sarcomas and hematological malignancies.

Purpose of the Study:

  • To explore the potential therapeutic applications of DUX4-targeting drugs beyond FSHD.
  • To investigate the feasibility of repurposing FSHD therapies for cancer treatment.
  • To establish a link between DUX4's role in muscular dystrophy and its oncogenic potential.

Main Methods:

  • Literature review of DUX4's function in FSHD and cancer.
  • Analysis of gene expression patterns in DUX4-related pathologies.
  • Comparative study of drug efficacy in FSHD models and cancer cell lines.

Main Results:

  • DUX4 expression is implicated in both FSHD pathogenesis and tumorigenesis.
  • Pharmacological agents developed for FSHD exhibit cytotoxic effects on cancer cells.
  • Repurposing FSHD drugs presents a promising avenue for novel cancer therapies.

Conclusions:

  • The DUX4 gene is a shared molecular target for both FSHD and certain cancers.
  • Existing and emerging FSHD therapies hold potential for treating DUX4-associated malignancies.
  • Targeting DUX4 offers a unified therapeutic strategy for distinct diseases.